Articles by Office of the Commissioner
For Immediate Release:
February 05, 2026
Today, the U.S. Food and Drug Administration took additional steps to support the transition of our nations food supply from the use of artificial petroleum�...
For Immediate Release:
January 11, 2026
The U.S. Food and Drug Administration today announced it is sharing information about the agencys flexible approach to overseeing chemistry, manufacturing an�...
For Immediate Release:
December 15, 2025
The U.S. Food and Drug Administration (FDA) today removed a key limitation on the use of real-world evidence (RWE) used in drug and device applications revi�...
For Immediate Release:
December 12, 2025
The U.S. Food and Drug Administration recently approved two new oral medicines to treat a common sexually transmitted infection called gonorrhea.
The FDA t�...
For Immediate Release:
December 11, 2025
Today, the U.S. Food and Drug Administration announced that it is taking action to advance sunscreen innovation, part of a broader initiative in the Office �...
For Immediate Release:
December 09, 2025
The U.S. Food and Drug Administration today approved Augmentin XR (amoxicillin-clavulanate potassium) under the Commissioner's National Priority Voucher (CN�...
For Immediate Release:
December 04, 2025
The U.S. Food and Drug Administration today approved a new indication for Breyanzi (Lisocabtagene maraleucel) as the first Chimeric Antigen Receptor (CAR) T�...
